The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 1 March 2004. doi:10.1084/jem.20030795
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 199, Number 5, 725-730
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 308K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lemos, M. P.
Right arrow Articles by Laufer, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lemos, M. P.
Right arrow Articles by Laufer, T. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*UniGene
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Brief Definitive Report

 MHC Class II Expression Restricted to CD8{alpha}+ and CD11b+ Dendritic Cells Is Sufficient for Control of Leishmania major

Maria P. Lemos1, Fatima Esquivel2, Phillip Scott2, and Terri M. Laufer1

1 Department of Medicine, and 2 Department of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104

Address correspondence to Terri M. Laufer, Dept. of Medicine, University of Pennsylvania, 753 BRB II/III, 421 Curie Blvd., Philadelphia, PA 19104. Phone: (215) 573-2975; Fax: (215) 573-7599; email: tlaufer{at}mail.med.upenn.edu

Control of the intracellular protozoan, Leishmania major, requires major histocompatibility complex class II (MHC II)–dependent antigen presentation and CD4+ T cell T helper cell 1 (Th1) differentiation. MHC II–positive macrophages are a primary target of infection and a crucial effector cell controlling parasite growth, yet their function as antigen-presenting cells remains controversial. Similarly, infected Langerhans cells (LCs) can prime interferon (IFN){gamma}–producing Th1 CD4+ T cells, but whether they are required for Th1 responses is unknown. We explored the antigen-presenting cell requirement during primary L. major infection using a mouse model in which MHC II, I-Aßb, expression is restricted to CD11b+ and CD8{alpha}+ dendritic cells (DCs). Importantly, B cells, macrophages, and LCs are all MHC II–negative in these mice. We demonstrate that antigen presentation by these DC subsets is sufficient to control a subcutaneous L. major infection. CD4+ T cells undergo complete Th1 differentiation with parasite-specific secretion of IFN{gamma}. Macrophages produce inducible nitric oxide synthase, accumulate at infected sites, and control parasite numbers in the absence of MHC II expression. Therefore, CD11b+ and CD8{alpha}+ DCs are not only key initiators of the primary response but also provide all the necessary cognate interactions for CD4+ T cell Th1 effectors to control this protozoan infection.

Key Words: Langerhans cells • CD4 • macrophages • Th1 • antigen presentation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS